Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial Download the PDF here. This post appeared first on investingnews.com Related Posts Share Purchase Plan Offer Booklet July 9, 2025 Strong Leach Recoveries and Low Impurities July 9, 2025 High Grade Cu-Au at Surface Delivers New Targets at Mankayan July 9, 2025